Article
Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.
Journal of autoimmunity - 1 May 2016
Kalyoncu Umut, Solmaz Dilek, Emmungil Hakan, Yazici Ayten, Kasifoglu Timucin, Kimyon Gezmiş, Balkarli Ayşe, Bes Cemal, Ozmen Mustafa, Alibaz-Oner Fatma, Erten Sükran, Cagatay Yonca, Cetin Gözde Yıldırım, Yilmaz Sedat, Yildiz Fatih, Pamuk Omer Nuri, Kucuksahin Orhan, Kilic Levent, Yazisiz Veli, Karadag Omer, Koca Süleyman Serdar, Hayran Mutlu, Akar Servet, Aksu Kenan, Akkoc Nurullah, Keser Gokhan, Gonullu Emel, Kisacik Bunyamin, Onat Ahmet Mesut, Soy Mehmet, Inanc Nevsun, Direskeneli Haner, Sayarlioglu Mehmet, Erken Eren, Turgay Murat, Cefle Ayse, Ertenli Ihsan, Pay Salih
Abstract excerpt
BACKGROUND: Adult-onset Still's disease (AOSD) is a rare condition, and treatment choices are frequently dependent on expert opinions. The objectives of the present study were to assess treatment modalities, disease course, and the factors influencing the outcome of patients with AOSD. METHODS: A multicenter study was used to reach sufficient patient numbers. The diagnosis of AOSD was based on the Yamaguchi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.